FDA clears SaluMedica's biomaterial nerve repair cuff:
This article was originally published in Clinica
Executive Summary
SaluMedica has received US FDA 510(k) clearance to market its biomaterial for use in peripheral nerve repair. The Salubria nerve cuff is a flexible tube that provides a protective environment to help peripheral nerves grow back together after they have been severed or damaged. Available with inner diameters of 2mm, 5mm and 10mm, it is made from the company's hydrogel, named Salubria. Atlanta, Georgia-based SaluMedica, which changed its name from Restore Therapeutics, says the product avoids the need to remove a vein or nerve from another part of the patient's body.
You may also be interested in...
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.